Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 15 for:    "Acute Lymphocytic Leukemia" | "Decitabine"

High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02551718
Recruitment Status : Recruiting
First Posted : September 16, 2015
Last Update Posted : March 4, 2019
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 1, 2020
Estimated Study Completion Date : July 1, 2022